Jing Ma

Title: Innovations of Jing Ma in Protein Domain Identification and Cancer Prognosis Prediction

Introduction

Jing Ma is an accomplished inventor based in Hangzhou, China, known for his significant contributions to the fields of protein domain identification and cancer prognosis prediction. With a total of two patents to his name, he has made strides in utilizing advanced methodologies to address complex biological challenges.

Latest Patents

One of Jing Ma's latest patents is titled "Method and system for identifying protein domain based on protein three-dimensional structure image." This invention discloses a method and system that identifies protein domains by leveraging structure similarity. It effectively addresses identification errors and omissions that arise from protein multi-sequence alignment errors, particularly when sequence consistency is low. The application constructs a point cloud segmentation model based on a dynamic graph convolutional neural network, integrating both global and local structural features to achieve simultaneous segmentation of the protein domain and acquisition of semantic labels.

Another notable patent is the "Multi-center synergetic cancer prognosis prediction system based on multi-source migration learning." This system comprises a model parameter setting module, a data screening module, and a multi-source migration learning module. The model parameter setting module is responsible for configuring cancer prognosis prediction model parameters. The data screening module, located at a clinical center, allows for the inquiry of sample feature and prognosis index data from a local database, facilitating data preprocessing. The multi-source migration learning module includes components for source model training, migration weight calculation, and target model computation.

Career Highlights

Jing Ma is currently associated with Zhejiang Lab, where he continues to innovate and develop cutting-edge solutions in his field. His work has garnered attention for its potential impact on both protein research and cancer treatment methodologies.

Collaborations

Jing collaborates with notable colleagues, including Jingsong Li and Yu Wang, who contribute to his research endeavors and enhance the collaborative environment at Zhejiang Lab.

Conclusion

Jing Ma's innovative patents reflect his dedication to advancing scientific knowledge and improving healthcare outcomes. His work in protein domain identification and cancer prognosis prediction showcases the potential of technology in addressing critical biological challenges.